Dr. Archana Laxmisan, MA, MD

Dr. Laxmisan practices at Sharp Coronado Hospital in San Diego, California.

Dr. Laxmisan's NPI, 1689841686, was assigned on May 9, 2008. Dr. Laxmisan graduated from University of Kerala Medical College in 2002. Dr. Laxmisan holds California license C56078.

Dr. Laxmisan's primary practice is Sharp Coronado Hospital, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (619) 522-3700.

Dr. Laxmisan's primary practice is Sharp Coronado Hospital in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Laxmisan to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Laxmisan practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Laxmisan's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Laxmisan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Laxmisan's licenses on file in 4 states: California, Texas, Georgia and Iowa.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, atrial fibrillation and flutter, cardiomyopathy, chronic diabetes, chronic hypertension and corns and calluses among the conditions Dr. Laxmisan treats.

CMS data shows 79 Medicare services from Dr. Laxmisan across 2 procedure codes in 2023, all of them office visits, for 15 Medicare patients. Medicare paid $3,774 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Dr. Laxmisan in 2024. The largest group is under 65, with 0 patients. Their average risk score is 1.36, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Laxmisan's median patient age at 47, with 70% women.

In 2024, Dr. Laxmisan wrote 186 Medicare Part D claims for 103 patients. 88% of them were for generic drugs. CMS names the drug for 27 of them, across 2 drugs with 11 or more claims each, at $362 in total drug cost. In 2023, CMS named 1,170 claims across 38 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Laxmisan for performance year 2024, reported as part of a group. Dr. Laxmisan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Laxmisan as offering telehealth.

Dmand AI links 15 papers to Dr. Laxmisan, published from 2004 to 2013. 2013 was the busiest year, with 5. The most frequent topics are Electronic Health Records, Colorectal Neoplasms and Continuity of Patient Care. Dr. Laxmisan has published most often in Appl Clin Inform. Dr. Laxmisan's most frequent co-authors are Hardeep Singh, MD, Daniel Robert Murphy, MBA, MD and Sameer M. Malhotra, MD.

Dr. Laxmisan graduated from University of Kerala Medical College in 2002. Dr. Laxmisan is a member of SHM.

Dr. Laxmisan is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.